INS and obesity due to melanocortin 4 receptor deficiency: In addition, upon HFD treatment, it was observed that there was an increase in fatty acid oxidation (elevated oxygen consumption, metabolic rate, and total energy expenditure), improved glucose tolerance and insulin sensitivity, as well as an attenuation of obesity and hepatic steatosis.